2015 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




Three-Year Data Presented From PYTHAGORAS Pivotal Trial of Lombard Medical's Aorfix

November 30, 2015 -- Lombard Medical, Inc. announced that efficacy and safety data from the 3-year follow-up of the United States PYTHAGORAS premarketing approval (P…

Boston Scientific’s AngioJet ZelanteDVT Receives FDA and CE Mark Approvals

November 30, 2015 -- Boston Scientific Corporation announced it has received US Food and Drug Administration and European CE Mark approval for the AngioJet ZelanteDVT thrombec…

Vascular Solutions Receives 510(k) Clearance for Enhanced R350 Guidewire

November 24, 2015 -- Vascular Solutions, Inc. announced that it has received 510(k) clearance from the US Food and Drug Administration for a new and enhanced version of the R3…

FDA Issues Safety Communication on Lubricious Coating Separation in Intravascular Medical Devices

November 23, 2015 -- The US Food and Drug Administration (FDA) issued a safety communication regarding lubricious coating separation on medical devices, including intrava…

Editorial Addresses European Industry Proposal to Withdraw Direct Sponsorships of Conference Attendees

November 23, 2015 -- Patrick W. Serruys, MD, Editor-in-Chief of EuroIntervention; William Wijns, MD, Chairman of PCR; and Stephan Windecker, President of EAPCI,…

Twelve-Month CARENET Data Presented for InspireMD’s CGuard Carotid EPS

November 20, 2015 -- InspireMD, Inc. announced positive 12-month follow-up data from the CARENET trial, which evaluated the company’s CGuard carotid embolic protect…

Four-Year INNOVATION Results Support Cordis InCraft AAA Stent Graft System

November 19, 2015 -- Cordis Corporation, a Cardinal Health company, announced that 4-year data from its INNOVATION of the InCraft abdominal aortic aneurysms (AAA) stent g…

Click here for more News coverage

Current Supplements

Sponsored by Cook Medical

Branching Out

Experts share their views on advancing endovascular technology.

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




Vascular Market Price  Change
Abbott Laboratories $45.32  0.89%
AstraZeneca PLC $34.75  2.06%
Boston Scientific Corporation $18.43  0.85%
BTG plc $617.00  0.08%
Cardinal Health $88.22  1.58%
Cardiovascular Systems Inc. $15.59  -2.59%
CR Bard Inc. $189.01  1.17%
Edwards Lifesciences Corp. $164.02  0.63%
Endologix Inc. $10.14  -0.39%
Hansen Medical, Inc. $2.99  5.77%
Vascular Market Price  Change
Johnson and Johnson $102.31  1.06%
Lombard Medical, Inc. $1.48  2.06%
Medtronic, Inc. $75.97  0.84%
Merit Medical Systems, Inc. $19.73  1.83%
St. Jude Medical Inc. $63.07  -0.05%
The Medicines Company $41.69  -0.76%
The Spectranetics Corporation $13.97  1.01%
TriVascular Technologies, Inc. $6.97  6.74%
Vascular Solutions Inc. $35.79  0.70%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media